Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to traclolimus (FK506)- or cyclosporine- based immunosuppression

Liver Transplantation and Surgery

Volumn 4, Issue 2, 1998, Pages 146-151

  Pham, H ^a   Lemoine, A ^a   Salvucci, M ^a   Azoulay, D ^a   Frenoy, N ^a   Samuel, D ^a   Reynes, M ^a   Bismuth, H ^a   Debuire, B ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OKT 3; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; GAMMOPATHY; GRAFT REJECTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0031883890     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040205     Document Type: Article

References (26)

1. 1 Calne RY, White DJG, Rolles K. Cyclosporine A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 30 kidneys, 2 pancreases, and 2 livers. Lancet 1979 ; 2: 1022–1023.
2. 2 Starzl TE, Porter KA, Iwatsuki S, Rosenthal JT, Shaw JRBW, Atchinson RW, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin‐steroid therapy. Lancet 1984 ; 1: 583–588. MEDLINE
3. 3 Penn I. Cancers following cyclosporine therapy. Transplantation 1987 ; 43: 32–35. MEDLINE
4. 4 Nalesnik MA. Involvement of the gastrointestinal tract by Epstein Barr virus associated posttransplant lymphoproliferative disorders. Am J Pathol 1990 ; 14: 92–100.
5. 5 Peest D, Schaper B, Nashan B, Wonigeit K, Raude E, Pilchlmayr R, et al. High incidence of monoclonal immunoglobulins in patients after liver or heart transplantation. Transplantation 1988 ; 46: 389–393. MEDLINE
6. 6 Deteix P, Chapuis‐Cellier C, Ghais Z, Lefrançois M, Brusa M, Touraine JL, et al. Systematic survey of immunoglobulin abnormalities: Frequency and evolution in organ‐transplant recipients. Transplant Proc 1985 ; 17: 2651–2654.
7. 7 Monk J, Calvin J, Price CP, Wreghitt TG. Oligoclonal banding in serum from heart‐transplant recipients. Clin Chem 1989 ; 35: 431–434. MEDLINE
8. 8 Pollock CA, Mahony JF, Ibels LS, Caters RJ, Waugh DA, Wells JV, et al. Immunoglobulin abnormalities in renal transplant recipients. Transplantation 1989 ; 47: 952–956. MEDLINE
9. 9 Myara I, Quenum G, Storogenko M, Tenenhaus D, Guillemain R, Moatti N. Monoclonal and oligoclonal gammopathies in heart‐transplant recipients. Clin Chem 1991 ; 37: 1334–1337. MEDLINE
10. 10 Hestin D, Petitpain N, Mayeux D, Renoux E, Chanliau J, Durand PY. Influence of chronic rejection on the occurrence of monoclonal gammopathies in renal transplants. Clin Transplant 1993 ; 7: 59–64.
11. 11 Touraine JL, Garnier JL, Lefrançois N, Finaz de Villaine J, Dubernard JM, de Thé G, et al. Severe lymphoproliferative disease and Kaposi sarcoma in transplant patients. Transplant Proc 1989 ; 21: 3197–3198. MEDLINE
12. 12 Pham H, Lemoine A, Sol O, Royer P, Azoulay D, Samuel D, et al. Monoclonal and oligoclonal gammopathies in liver‐transplant recipients. Transplantation 1994 ; 58: 253–257. MEDLINE
13. 13 Cockburn I. Assessment of the risk of malignancy and lymphomas developing in patients using Sandimmune. Transplant Proc 1987 ; 19: 1804–1807. MEDLINE
14. 14 Gruber SA, Skjei KL, Sothern RB. Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression. Transplant Proc 1991 ; 23: 1104–1105. MEDLINE
15. 15 Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Study Group. Lancet 1994 ; 344: 423–428. MEDLINE
16. 16 Kyle RA. The monoclonal gammopathies. Clin Chem 1994 ; 40: 2154–2161. MEDLINE
17. 17 L'Hermine A, Tricottet V, Bernheim A, Samuel D, Sebagh M, Bismuth H, et al. Detection of Y chromosome by fluorescent in situ hybridization in six cases of lymphoproliferative disorders after sex‐mismatched liver transplantation. J Hepatol 1996 ; 25 (suppl 1): 61 [abstract].
18. 18 Sambrook J, Fritsch EF, Maniatis T. Analysis and cloning of evcaryotic genomic DNA. In Ford N, Nolan C, Ferguson M, (eds). Molecular cloning, a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989 ; 38–46.
19. 19 Potter MN, Steward CG, Maitland NJ, Oakhill A. Detection of clonality in childhood acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia 1992 ; 6: 289–294. MEDLINE
20. 20 Ngan BBY, Nourse J, Cleary ML. Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl‐2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 1989 ; 73: 1759–1762. MEDLINE
21. 21 Gauwerky CE, Haluska FG, Tsujimoto Y, Nowell PC, Croce CM. Evolution of B‐cell malignancy: Pre‐B‐cell leukemia resulting from MYC activation in a B‐cell neoplasm with a rearranged BCL2 gene. Proc Natl Acad Sci USA 1988 ; 85: 8548–8552. MEDLINE
22. 22 Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ. Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 1988 ; 85: 4869–4873. MEDLINE
23. 23 Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG, et al. Development of monoclonal gammopathy precedes the development of Epstein‐Barr virus‐induced posttransplant lymphoproliferative disorder. Liver Transplant Surg 1996 ; 5: 375–382.
24. 24 Starzl TE, Fung J, Venkataramanan R, Todo S, Demetris AJ, Jain A. FK506 for liver, kidney and pancreas transplantation. Lancet 1989 ; 2: 1000–1004. MEDLINE
25. 25 Reanard TH, Andrews WS, Foster ME. Relationship between OKT3 administration, EBV seroconversion and the lymphoproliferative syndrome in pediatric liver transplant recipients. Transplant Proc 1991 ; 23: 1473–1475. MEDLINE
26. 26 Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Transplantation 1996 ; 62: 370–376. MEDLINE